cefotetan has been researched along with Adnexitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, LR; Jaeger, JR; Peter, NG | 1 |
| Cohen, CR; Gichuhi, JW; Kiehlbauch, JA; Meier, A; Mugo, NR; Nguti, R; Stamm, WE | 1 |
| Berkeley, AS; Eschenbach, DA; Faro, S; Hemsell, DL; Ledger, WJ; Little, BB; Pastorek, JG; Sweet, RL; Wölner-Hanssen, P | 1 |
| Dodson, MG | 1 |
| Castellano, MA; Faro, S; Gentry, LO; Ismail, M; Knuppel, RA; Kreutner, AK; Lamb, EJ; LeFrock, JL; Poindexter, AN; Ritter, M | 1 |
| Landers, DV; Ohm-Smith, M; Robbie, MO; Schachter, J; Sweet, RL | 1 |
| Ford, LC; Hammill, HA; Nilsson, JD | 1 |
| Gall, SA; Gibbs, RS; Hemsell, DL; Knuppel, RA; Lane, TW; Newton, ER; Sweet, RL; Wendel, GD | 1 |
| Knuppel, RA; Lake, M; O'Bryan, D | 1 |
| Chimura, T; Inoue, K; Morisaki, J; Morisaki, N; Watanabe, T | 1 |
| Ohm-Smith, MJ; Sweet, RL | 1 |
2 review(s) available for cefotetan and Adnexitis
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome: a diagnosis to consider in women with right upper quadrant pain.
Topics: Abdominal Pain; Anti-Bacterial Agents; Cefotetan; Diagnosis, Differential; Female; Gonorrhea; Hepatitis; Humans; Pelvic Inflammatory Disease; Syndrome | 2004 |
Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefotetan; Cefoxitin; Chlamydia Infections; Chlamydia trachomatis; Clindamycin; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Tetracycline Resistance | 1994 |
4 trial(s) available for cefotetan and Adnexitis
| Article | Year |
|---|---|
Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
Topics: Acute Disease; Adolescent; Adult; Cefotetan; Cefoxitin; Centers for Disease Control and Prevention, U.S.; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Gentamicins; Hospitalization; Humans; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Prospective Studies; Severity of Illness Index; United States | 1994 |
Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
Topics: Acute Disease; Adolescent; Adult; Cefotetan; Cefoxitin; Cephamycins; Chlamydia Infections; Doxycycline; Drug Therapy, Combination; Female; Gonorrhea; Hospitalization; Humans; Pelvic Inflammatory Disease | 1988 |
Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
Topics: Acute Disease; Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Cross Infection; Endometritis; Female; Genital Diseases, Female; Humans; Pelvic Inflammatory Disease; Random Allocation | 1988 |
Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
Topics: Adult; Bacteria; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Chorioamnionitis; Endometritis; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Random Allocation | 1988 |
5 other study(ies) available for cefotetan and Adnexitis
| Article | Year |
|---|---|
Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Case-Control Studies; Cefotetan; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Female; Follow-Up Studies; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Injections, Intravenous; Laparoscopy; Length of Stay; Pelvic Inflammatory Disease; Prevalence; Probability; Prospective Studies; Risk Assessment; Salpingitis; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2006 |
Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cephamycins; Cross Infection; Endometritis; Female; Genital Diseases, Female; Humans; Pelvic Inflammatory Disease; Postoperative Complications | 1988 |
Effects of cefotetan disodium, cefoxitin, cefazolin, and cefotaxime in vitro on polymorphonuclear leukocytes from patients with leukopenia and severe pelvic inflammatory disease.
Topics: Cefazolin; Cefotaxime; Cefotetan; Cefoxitin; Cephalosporins; Cephamycins; Chemotaxis, Leukocyte; Female; Humans; Leukopenia; Neutrophils; Pelvic Inflammatory Disease | 1988 |
[Prophylactic and therapeutic use of cefotetan, a cephem antibiotic, for infections in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; Cefotetan; Cephamycins; Cesarean Section; Female; Humans; Hysterectomy; Middle Aged; Ovariectomy; Pelvic Inflammatory Disease; Pregnancy; Premedication; Puerperal Infection | 1986 |
In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Cefmetazole; Cefotetan; Cephamycins; Clavulanic Acid; Clavulanic Acids; Endometritis; Female; Humans; Microbial Sensitivity Tests; Pelvic Inflammatory Disease | 1987 |